Page last updated: 2024-08-23

elliptinium and Soft Tissue Neoplasms

elliptinium has been researched along with Soft Tissue Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amiel, JL; Brule, G; Callet, B; Droz, JP; Huertas, D; Le Chevalier, T; Le Pecq, JB; Paoletti, C; Rouesse, J; Sancho-Garnier, H; Tursz, T; Voisin, PM1
Rouësse, J; Somers, R; Thomas, D; van Oosterom, A1
Amiel, JL; Caille, P; De Jager, R; Le Chevalier, T; May-Levin, F; Mondesir, JM; Rouësse, JG; Sancho-Garnier, H; Spielmann, M1

Other Studies

3 other study(ies) available for elliptinium and Soft Tissue Neoplasms

ArticleYear
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].
    La Nouvelle presse medicale, 1981, May-30, Volume: 10, Issue:24

    Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Ellipticines; Hemolysis; Humans; Kidney Neoplasms; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms

1981
Phase II study of elliptinium in metastatic soft tissue sarcoma.
    European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:5

    Topics: Adult; Aged; Alkaloids; Drug Evaluation; Ellipticines; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms

1985
Phase II study of elliptinium in advanced breast cancer.
    Cancer treatment reports, 1985, Volume: 69, Issue:6

    Topics: Acute Kidney Injury; Adult; Aged; Alkaloids; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Ellipticines; Female; Hemolysis; Humans; Immunoglobulin M; Middle Aged; Soft Tissue Neoplasms

1985